Rare Diseases: Drug Discovery and Informatics Resource

Area of Science:

• Biomedical Informatics
• Pharmacology
• Genetics

Background:

• Rare diseases, though individually uncommon, collectively affect millions globally.
• Drug development for rare diseases faces challenges due to small markets and complex etiologies.
• Recent advancements in computational biology and informatics are crucial for rare disease research.

Purpose of the Study:

• To highlight the growing importance of computational biology in rare disease drug discovery.
• To discuss the role of informatics databases in accelerating pre-clinical development.
• To address the gap between basic research and unmet patient needs in rare diseases.

Main Methods:

• Review of current trends in rare disease drug development (gene therapy, enzyme replacement, drug repositioning).
• Analysis of the growth and components of rare disease informatics databases (drug targets, genetic variants, phenotypes, patient registries).
• Exploration of how computational models leverage these databases for target identification and lead optimization.

Main Results:

• Informatics databases for rare diseases have expanded significantly, covering targets, genetics, phenotypes, and patient data.
• Computational biology approaches are increasingly recognized for their potential in rare disease research.
• The integration of databases and computational models shows promise for accelerating drug discovery.

Conclusions:

• Computational biology and informatics databases are vital tools for advancing rare disease drug discovery.
• These advancements are essential for bridging the gap between research and patient needs.
• New computational models are expected to expedite pre-clinical development for rare disease therapies.